Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Thierry Bouyssou (Warthausen, Germany), Thierry Bouyssou, Birgit Jung, Peter Nickolaus, Jeff Duan, Feihong Dai, Henri Doods. Anti-inflammatory activity of the bradykinin B1R antagonist in a model of LPS-induced lung inflammation in cynomolgus monkey. Eur Respir J 2016; 48: Suppl. 60, 5063

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: Anti-inflammatory effects of diphenyleneiodonium in lipopolysaccharide-induced acute lung injury in rats Source: International Congress 2015 – Acute critical care: COPD, muscles and weaning Year: 2015 Deficiency or inhibition of lysophosphatidic acid receptor 1 protects against hyperoxia-induced lung injury in neonatal rats Source: International Congress 2015 – Neonatal and paediatric intensive care Year: 2015 Effect of doxofylline on LPS-induced leukocyte migration to the lung Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Bcl-2 antagonist ABT-737 attenuates corticosteroid-insensitive neutrophilic airway inflammation Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 Anti-inflammatory effects of roflumilast N-oxide and dexamethasone in human bronchial epithelial cells stimulated with toll-like receptor agonists Source: Annual Congress 2013 –The pulmonary epithelium: recent developments Year: 2013 Acute protective effect of estradiol on lung inflammation induced by an intestinal ischemic insult in male rats Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 AZD7624, an inhaled p38 inhibitor for COPD, attenuates lung and systemic inflammation after LPS Challenge in humans Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015 Abrogation of bleomycin induced inflammation and lung fibrosis by angiotensin AT1 receptor antagonist. Relevance of PGE-2 modulation Source: Eur Respir J 2005; 26: Suppl. 49, 82s Year: 2005 CHI-91040, a novel inhaled p38α inhibitor, counteracts lung inflammation induced by IL-1β in the rat Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 The anti-inflammatory effects of eucalyptol in a mouse model of LPS-induced pulmonary inflammation are mediated by TRPM8 Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models Year: 2016 Effects of a highly selective CXCR3 antagonist in two murine models of lung inflammation Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014 LASSBio 596 improves function, inflammation and apoptosis in lung and liver of mice intoxicated with microcystin-LR Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury Year: 2015 Alpha-7 nicotinic receptor stimulation reduces airway inflammation in a murine model of asthma Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 Neutrophil elastase inhibitor sivelestat ameliorates gefitinib, naphthalene-induced acute pneumonitis in mice Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury Year: 2015 Effect of retinoid X receptor partial agonist on airway inflammation and hyperresponsiveness Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014 Pioglitazone attenuates endotoxin-induced acute lung injury by reducing neutrophil recruitment Source: Eur Respir J 2012; 40: 416-423 Year: 2012 Selective endothelin-A receptor blockade attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Ghrelin attenuates lipopolysaccharide-induced acute lung injury Source: Eur Respir J 2005; 26: Suppl. 49, 731s Year: 2005 cPLA2alpha inhibitor ASB14780 suppresses airway MMP-9 production and improves respiratory function in cigarette-smoke induced model Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014